Xuemei Yi

Tongji University School of Medicine

2
Articles

About

Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institue of Psoriasis, Tongji University School of Medicine, Shanghai, China

Latest publication

Journal article

Ixekizumab four-week dosing is comparable to two-week dosing in psoriasis patients and reduces treatment costs: experience in a real-world setting over a 12-week period

In European Journal of Dermatology (2022/5 Vol. 32)


Most viewed articles

Journal article

Safety and efficacy of secukinumab in psoriasis patients infected with hepatitis B virus: a retrospective study

In European Journal of Dermatology (2022/3 Vol. 32)


Co-authors

  • Ning Yu

    Tongji University School of Medicine

    3
    Articles
  • Yangfeng Ding

    Tongji University School of Medicine

    4
    Articles
  • Yuling Shi

    Tongji University School of Medicine

    3
    Articles
  • Hui Qin

    Tongji University School of Medicine

    2
    Articles
  • Na Liu

    Tongji University School of Medicine

    3
    Articles
  • Yifan Hu

    Tongji University School of Medicine

    1
    Article
  • Yunlu Gao

    Tongji University School of Medicine

    1
    Article
  • Fujuan Chen

    Tongji University School of Medicine

    2
    Articles
  • Jun Gu

    Tongji University School of Medicine

    1
    Article
  • Yu Wang

    University of Macau

    5
    Articles
  • Ying Li

    Fudan University

    2
    Articles
  • Jiajing Lu

    Tongji University School of Medicine

    1
    Article
  • Yingyuan Yu

    Tongji University School of Medicine

    1
    Article

Articles

This action will reload the page results.
Journal article

Ixekizumab four-week dosing is comparable to two-week dosing in psoriasis patients and reduces treatment costs: experience in a real-world setting over a 12-week period

In European Journal of Dermatology (2022/5 Vol. 32)

Journal article

Safety and efficacy of secukinumab in psoriasis patients infected with hepatitis B virus: a retrospective study

In European Journal of Dermatology (2022/3 Vol. 32)